DF Dent & Co’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $781K | Buy |
5,115
+1,784
| +54% | +$273K | 0.02% | 176 |
|
|
2025
Q4 | $459K | Sell |
3,331
-2,334
| -41% | -$306K | 0.01% | 212 |
|
|
2025
Q3 | $726K | Buy |
5,665
+2,163
| +62% | +$264K | 0.01% | 197 |
|
|
2025
Q2 | $424K | Hold |
3,502
| – | – | 0.01% | 202 |
|
|
2025
Q1 | $390K | Buy |
3,502
+37
| +1% | +$3.94K | 0.01% | 213 |
|
|
2024
Q4 | $337K | Hold |
3,465
| – | – | ﹤0.01% | 218 |
|
|
2024
Q3 | $399K | Sell |
3,465
-360
| -9% | -$40.8K | ﹤0.01% | 210 |
|
|
2024
Q2 | $407K | Sell |
3,825
-4
| -0.1% | -$402 | 0.01% | 194 |
|
|
2024
Q1 | $370K | Buy |
3,829
+22
| +0.6% | +$2.26K | ﹤0.01% | 216 |
|
|
2023
Q4 | $384K | Hold |
3,807
| – | – | 0.01% | 206 |
|
|
2023
Q3 | $388K | Hold |
3,807
| – | – | 0.01% | 207 |
|
|
2023
Q2 | $384K | Hold |
3,807
| – | – | 0.01% | 209 |
|
|
2023
Q1 | $350K | Buy |
3,807
+170
| +5% | +$14.8K | ﹤0.01% | 205 |
|
|
2022
Q4 | $330K | Buy |
3,637
+30
| +0.8% | +$2.53K | ﹤0.01% | 207 |
|
|
2022
Q3 | $274K | Buy |
3,607
+115
| +3% | +$9.53K | ﹤0.01% | 209 |
|
|
2022
Q2 | $295K | Buy |
3,492
+125
| +4% | +$11K | ﹤0.01% | 201 |
|
|
2022
Q1 | $295K | Sell |
3,367
-12
| -0.4% | -$1.04K | ﹤0.01% | 218 |
|
|
2021
Q4 | $296K | Sell |
3,379
-2,000
| -37% | -$166K | ﹤0.01% | 216 |
|
|
2021
Q3 | $440K | Sell |
5,379
-96
| -2% | -$8.64K | ﹤0.01% | 188 |
|
|
2021
Q2 | $500K | Hold |
5,475
| – | – | 0.01% | 185 |
|
|
2021
Q1 | $468K | Hold |
5,475
| – | – | 0.01% | 182 |
|
|
2020
Q4 | $517K | Hold |
5,475
| – | – | 0.01% | 168 |
|
|
2020
Q3 | $476K | Hold |
5,475
| – | – | 0.01% | 158 |
|
|
2020
Q2 | $478K | Buy |
5,475
+325
| +6% | +$28.1K | 0.01% | 150 |
|
|
2020
Q1 | $425K | Sell |
5,150
-138
| -3% | -$12.3K | 0.01% | 157 |
|
|
2019
Q4 | $501K | Buy |
5,288
+3
| +0.1% | +$269 | 0.01% | 172 |
|
|
2019
Q3 | $459K | Hold |
5,285
| – | – | 0.01% | 170 |
|
|
2019
Q2 | $483K | Sell |
5,285
-613
| -10% | -$51.9K | 0.01% | 171 |
|
|
2019
Q1 | $508K | Buy |
5,898
+837
| +17% | +$67.2K | 0.01% | 173 |
|
|
2018
Q4 | $389K | Hold |
5,061
| – | – | 0.01% | 186 |
|
|
2018
Q3 | $391K | Hold |
5,061
| – | – | 0.01% | 203 |
|
|
2018
Q2 | $343K | Hold |
5,061
| – | – | 0.01% | 202 |
|
|
2018
Q1 | $367K | Buy |
+5,061
| New | +$385K | 0.01% | 201 |
|
|
2016
Q1 | – | Sell |
-3,000
| Closed | -$231K | – | 167 |
|
|
2015
Q4 | $231K | Buy |
+3,000
| New | +$238K | 0.01% | 152 |
|
Other funds holding NVS
DF Dent & Co's NVS Position: Q1 2026 in Review
DF Dent & Co increased its Novartis (NVS) stake by 54% in Q1 2026, buying an estimated $273K and bringing the position to 5,115 shares worth $781K. The position accounts for 0.02% of the portfolio, ranked #176.
DF Dent & Co first reported a position in NVS in Q4 2015 and has held it in 34 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- DF Dent & Co held 5,115 shares of Novartis worth $781K as of Q1 2026.
- DF Dent & Co bought 1,784 Novartis shares in Q1 2026, an estimated $273K.
- Novartis made up 0.02% of DF Dent & Co's portfolio in Q1 2026, its #176 holding.
- DF Dent & Co first reported a position in Novartis in Q4 2015 and has held it in 34 quarters since.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on DF Dent & Co's 13F filing for Q1 2026, filed 15 May 2026.